Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-04
2006-07-04
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S338000, C546S273400, C546S194000, C546S256000
Reexamination Certificate
active
07071216
ABSTRACT:
New substituted benz-azole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
REFERENCES:
patent: 6211177 (2001-04-01), Sperl et al.
patent: 6248771 (2001-06-01), Shenoy et al.
patent: 6399603 (2002-06-01), Jacobs et al.
patent: 6417194 (2002-07-01), Fox et al.
patent: WO 00/62778 (2000-10-01), None
patent: WO 01/66539 (2001-09-01), None
patent: WO 02/42273 (2002-05-01), None
patent: WO 02/44156 (2002-06-01), None
patent: WO 02/076960 (2002-10-01), None
patent: WO 02/094808 (2002-11-01), None
patent: WO 03/082272 (2003-10-01), None
patent: WO 2004/085425 (2004-10-01), None
Amiri Payman
Fantl Wendy
Hansen Teresa
Levine Barry Haskell
McBride Christopher
Chiron Corporation
Harbin Alisa A.
Shelton Dennis K.
Stockton Laura L.
Suh Young J.
LandOfFree
Substituted benz-azoles and methods of their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benz-azoles and methods of their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benz-azoles and methods of their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3576510